Brief overview on dengue viral disease
DOI:
https://doi.org/10.7439/ijbar.v8i4.4060Keywords:
dry eye, keratoconjunctivitis sicca, inflammationAbstract
Dengue is an arthropod-borne flavivirus belongs to Flaviviridae family and it comprises of four serotypes i.e. DENV-1, DENV-2, DENV-3 and DENV-4. Laboratory diagnosis of this disease can be executed by various commercially available serological based diagnostic kits but the sensitivity and specificity of these kits varies from each other. The cell culture and / or molecular based diagnostic kits are also used at very high-end set-up, hence, it does not to be reached for general public. Although in absence of an anti-viral drugs and vaccines, the only control measures have to reduce the vector, means, prevention of dengue disease is better than cure.
Downloads
References
American Mosquito Control Association (2014). www.http://www.mosquito.org/mosquito-borne-diseases, AMCA, 2014.
Caraballo Hector. Emergency Department Management of Mosquito-Borne Illness: Malaria, Dengue, and West Nile Virus. Emergency Medicine Practice. 2014; 16 (5).
Centers for Disease Control and Prevention (2016). National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Vector-Borne Diseases (DVBD), https://www.cdc.gov/dengue/
WHO/TDR (2009). Dengue guidelines for diagnosis, treatment, prevention and control (new edition), Geneva; World health Organization and the Special Programme for research and training in Tropical Disease (http://whqlibdoc.who.int/publication/2009 /978924154787_eng.pdf.accessed12 March, 2016).
WHO (2012b). Global strategy for dengue prevention and control 2012-2020, Geneva, World Health Organization (http://apps.who.int/tris/bitstream/10665/75303/1/ 9789241504034_eng.pdf.accessed12 March, 2016).
WHO/TDR (2016). Technical Handbook, Technical handbook for dengue surveillance, dengue outbreak prediction / detection and outbreak response (
Guzman M.G. et al. Dengue: A continuing global threat. Nat. Rev. Microbiol 2010; 8: S7-16.
National Guidelines for Clinical Management of Dengue Fever (2014); National Vector Borne Disease Control Programme India.
Elizabeth A. et al. Performance of Dengue Diagnostic Tests in a Single-Specimen Diagnostic Algorithm. Journal of Infectious Diseases; 2016; 214(6) 836-844, doi: 10.1093/infdis/jiw103.
World Health Organization (2010). First report on neglected tropical diseases: working to overcome the global impact of neglected tropical diseases. Geneva.
Annual Report (2014-15). National Vector Borne Disease Control Programme India.
Guzman, M.G. & Kouri, G, Dengue: An update. Lancet Infect. Dis. 202; 2: 33-42.
Chao D. Y. et al. Comparison of E and NS1 antigens capture ELISA to detect dengue viral antigens from mosquitoes. J. Vector Borne Diseases, 2015; 52(2); 134-41.
Dennis Normile (2013). Surprising New Dengue Virus Throws a Spanner in Disease Control Efforts. Science 2013; 342 (6157): 415. DOI: 10.1126/science.342. 6157. 415).
Baruah K, Dhariwal AC. (2011). Epidemiology of dengue, its prevention and control in India. Journal of Indian Medical Association. 109 (2):82
Baruah K, Biswas A, Suneesh K, Dhariwal AC. (2014). Dengue fever: Epidemiology and clinical pathogenesis. Chapter 13, Major tropical diseases: Public health perspective. Goa: Broadway publishing House; 255
Murray NEA, Quam MB, Wilder-Smith A. Epidemiology of dengue: Past, present and future prospects. Clin Epidemiol 2013; 5: 299
Gan VC, et al. Diagnosing dengue at the point-of-care: Utility of a rapid combined diagnostic kit in Singapore. PloS One 2014; 9(3): e90037.
Parida M, et al. Rapid detection and differentiation of dengue virus serotypes by a real-time reverse transcription-loop-mediated isothermal amplification assay. J Clin Microbiol; 2005; 43(6): 2895-903.
Valdez Sandoval J.J. et al. Evaluation of the SD Dengue Duo diagnosis system for detection of NS1 protein and IgM and IgG dengue antibodies. Rev Cubana Med Trop; 2012; 64(1): 27
Dussart P, et al. Evaluation of two new commercial tests for the diagnosis of acute dengue virus infection using NS1 antigen detection in human serum. PLoSNegl Trop Dis 2008; 2(8): e280.
Hermann L.L. et al. Evaluation of a Dengue NS1 antigen detection assay sensitivity and specificity for the diagnosis of acute dengue virus infection. PLoS Negl Trop Dis 2014; 8(10): e3193.
Pal S, et al. Evaluation of Dengue NS1 antigen rapid tests and ELISA kits using clinical samples. PloS One; 9(11): e11341.
Shubhanker Mitra et al. Comparative evaluation of validity and cost-benefit analysis of rapid diagnostic test (RDT) kits in diagnosis of dengue infection using composite reference criteria: A cross-sectional study from south India. J Vector Borne Dis 2016; 53: 30
Kumarasamy V. et al. A comparative study on the performance of two commercial anti-dengue IgM assays Kits. Med. J. Malaysia, 2006; 62(1).
Vorndam, V. & Kuno, G. (1997). In Dengue and Dengue Hemorrhagic Fever (Gubler, D.J & Kuno, G. eds), 313-333. CAB International, New York, USA.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
How to Cite
